{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:40:29Z","timestamp":1794580829939,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003493","name":"Gemeinn\u00fctzige Hertie\u2010Stiftung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003493","id-type":"DOI","asserted-by":"crossref"}]},{"name":"LMU FoeFoLe","award":["1032"],"award-info":[{"award-number":["1032"]}]},{"name":"LMU FoeFoLe","award":["1119"],"award-info":[{"award-number":["1119"]}]},{"name":"SyNergy excellence cluster","award":["EXC 2145\/ID 390857198"],"award-info":[{"award-number":["EXC 2145\/ID 390857198"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2023,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Microglial activation occurs early in Alzheimer's disease (AD) and previous studies reported both detrimental and protective effects of microglia on AD progression. Here, we used CSF sTREM2 to investigate disease stage\u2010dependent drivers of microglial activation and to determine downstream consequences on AD progression. We included 402 patients with measures of earliest beta\u2010amyloid (CSF A\u03b2\n                    <jats:sub>1\u201042<\/jats:sub>\n                    ) and late\u2010stage fibrillary A\u03b2 pathology (amyloid\u2010PET centiloid), as well as sTREM2, p\u2010tau\n                    <jats:sub>181<\/jats:sub>\n                    , and FDG\u2010PET. To determine disease stage, we stratified participants into early A\u03b2\u2010accumulators (A\u03b2 CSF+\/PET\u2212;\n                    <jats:italic>n<\/jats:italic>\n                    \u00a0=\u00a070) or late A\u03b2\u2010accumulators (A\u03b2 CSF+\/PET+;\n                    <jats:italic>n<\/jats:italic>\n                    \u00a0=\u00a0201) plus 131 controls. In early A\u03b2\u2010accumulators, higher centiloid was associated with cross\u2010sectional\/longitudinal sTREM2 and p\u2010tau\n                    <jats:sub>181<\/jats:sub>\n                    increases. Further, higher sTREM2 mediated the association between centiloid and cross\u2010sectional\/longitudinal p\u2010tau\n                    <jats:sub>181<\/jats:sub>\n                    increases and higher sTREM2 was associated with FDG\u2010PET hypermetabolism. In late A\u03b2\u2010accumulators, we found no association between centiloid and sTREM2 but a cross\u2010sectional association between higher sTREM2, higher p\u2010tau\n                    <jats:sub>181<\/jats:sub>\n                    and glucose hypometabolism. Our findings suggest that a TREM2\u2010related microglial response follows earliest A\u03b2 fibrillization, manifests in inflammatory glucose hypermetabolism and may facilitate subsequent p\u2010tau\n                    <jats:sub>181<\/jats:sub>\n                    increases in earliest AD.\n                  <\/jats:p>","DOI":"10.15252\/emmm.202216987","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T03:56:48Z","timestamp":1673236608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["sTREM2 is associated with amyloid\u2010related p\u2010tau increases and glucose hypermetabolism in Alzheimer's disease"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2597-1992","authenticated-orcid":false,"given":"Davina","family":"Biel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-569X","authenticated-orcid":false,"given":"Marc","family":"Su\u00e1rez\u2010Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rubinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dewenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Steward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Roemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Haass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9247-2843","authenticated-orcid":false,"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9736-2283","authenticated-orcid":false,"given":"Nicolai","family":"Franzmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer's Disease Neuroimaging Initiative (ADNI)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"BFEMMM202216987_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neurobiolaging.2017.06.016","volume":"59","author":"EM Arenaza\u2010Urquijo","year":"2017","unstructured":"Arenaza\u2010Urquijo EM, Bejanin A, Gonneaud J, Wirth M, La Joie R, Mutlu J, Gaubert M, Landeau B, de la Sayette V, Eustache F et\u00a0al (2017) Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation. Neurobiol Aging 59: 72\u201379","journal-title":"Neurobiol Aging"},{"key":"BFEMMM202216987_CR2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00259-014-2919-z","volume":"42","author":"A Ashraf","year":"2015","unstructured":"Ashraf A, Fan Z, Brooks DJ, Edison P (2015) Cortical hypermetabolism in MCI subjects: a compensatory mechanism? Eur J Nucl Med Mol Imaging 42: 447\u2013458","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BFEMMM202216987_CR3","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.neuroimage.2010.09.025","volume":"54","author":"BB Avants","year":"2011","unstructured":"Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC (2011) A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 54: 2033\u20132044","journal-title":"Neuroimage"},{"key":"BFEMMM202216987_CR4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.61.3.378","volume":"61","author":"DA Bennett","year":"2004","unstructured":"Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE (2004) Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 61: 378\u2013384","journal-title":"Arch Neurol"},{"key":"BFEMMM202216987_CR5","doi-asserted-by":"crossref","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","volume":"110","author":"TL Benzinger","year":"2013","unstructured":"Benzinger TL, Blazey T, Jack CR Jr, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ et\u00a0al (2013) Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci USA 110: E4502\u2013E4509","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM202216987_CR6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","volume":"68","author":"K Bhaskar","year":"2010","unstructured":"Bhaskar K, Konerth M, Kokiko\u2010Cochran ON, Cardona A, Ransohoff RM, Lamb BT (2010) Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68: 19\u201331","journal-title":"Neuron"},{"key":"BFEMMM202216987_CR7","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4980","volume":"7","author":"JH Brelstaff","year":"2021","unstructured":"Brelstaff JH, Mason M, Katsinelos T, McEwan WA, Ghetti B, Tolkovsky AM, Spillantini MG (2021) Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates. Sci Adv 7: eabg4980","journal-title":"Sci Adv"},{"key":"BFEMMM202216987_CR8","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1093\/brain\/awac257","volume":"145","author":"KB Casaletto","year":"2022","unstructured":"Casaletto KB, Nichols E, Aslanyan V, Simone SM, Rabin JS, LaJoie R, Brickman AM, Dams\u2010O'Connor K, Palta P, Kumar RG et\u00a0al (2022) Sex\u2010specific effects of microglial activation on Alzheimer's disease proteinopathy in older adults. Brain 145: 3536\u20133545","journal-title":"Brain"},{"key":"BFEMMM202216987_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-018-0262-8","volume":"13","author":"PJ Cheng\u2010Hathaway","year":"2018","unstructured":"Cheng\u2010Hathaway PJ, Reed\u2010Geaghan EG, Jay TR, Casali BT, Bemiller SM, Puntambekar SS, von Saucken VE, Williams RY, Karlo JC, Moutinho M et\u00a0al (2018) The Trem2 R47H variant confers loss\u2010of\u2010function\u2010like phenotypes in Alzheimer's disease. Mol Neurodegener 13: 29","journal-title":"Mol Neurodegener"},{"key":"BFEMMM202216987_CR10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav6221","volume":"11","author":"M Ewers","year":"2019","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez\u2010Calvet M, Morenas\u2010Rodriguez E, Caballero MAA, Kleinberger G, Piccio L, Cruchaga C, Deming Y, Dichgans M et\u00a0al (2019) Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease. Sci Transl Med 11: eaav6221","journal-title":"Sci Transl Med"},{"key":"BFEMMM202216987_CR11","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012308","volume":"12","author":"M Ewers","year":"2020","unstructured":"Ewers M, Biechele G, Suarez\u2010Calvet M, Sacher C, Blume T, Morenas\u2010Rodriguez E, Deming Y, Piccio L, Cruchaga C, Kleinberger G et\u00a0al (2020) Higher CSF sTREM2 and microglia activation are associated with slower rates of beta\u2010amyloid accumulation. EMBO Mol Med 12: e12308","journal-title":"EMBO Mol Med"},{"key":"BFEMMM202216987_CR12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jamaneurol.2014.3314","volume":"72","author":"AS Fleisher","year":"2015","unstructured":"Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gutierrez Gomez M, Langois CM, Langbaum JB, Roontiva A, Thiyyagura P, Lee W et\u00a0al (2015) Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross\u2010sectional study. JAMA Neurol 72: 316\u2013324","journal-title":"JAMA Neurol"},{"key":"BFEMMM202216987_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-020-00407-2","volume":"15","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier N, Suarez\u2010Calvet M, Frontzkowski L, Moore A, Hohman TJ, Morenas\u2010Rodriguez E, Nuscher B, Shaw L, Trojanowski JQ, Dichgans M et\u00a0al (2020) Higher CSF sTREM2 attenuates ApoE4\u2010related risk for cognitive decline and neurodegeneration. Mol Neurodegener 15: 57","journal-title":"Mol Neurodegener"},{"key":"BFEMMM202216987_CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, Hari\u2010Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C et\u00a0al (2018) Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Lancet Neurol 17: 241\u2013250","journal-title":"Lancet Neurol"},{"key":"BFEMMM202216987_CR15","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210542","volume":"218","author":"M Gratuze","year":"2021","unstructured":"Gratuze M, Chen Y, Parhizkar S, Jain N, Strickland MR, Serrano JR, Colonna M, Ulrich JD, Holtzman DM (2021) Activated microglia mitigate Abeta\u2010associated tau seeding and spreading. J Exp Med 218: e20210542","journal-title":"J Exp Med"},{"key":"BFEMMM202216987_CR16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001694","volume":"20","author":"C Haass","year":"2022","unstructured":"Haass C, Selkoe D (2022) If amyloid drives Alzheimer disease, why have anti\u2010amyloid therapies not yet slowed cognitive decline? PLoS Biol 20: e3001694","journal-title":"PLoS Biol"},{"key":"BFEMMM202216987_CR17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O (2021) Biomarkers for neurodegenerative diseases. Nat Med 27: 954\u2013963","journal-title":"Nat Med"},{"key":"BFEMMM202216987_CR18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12974-018-1309-z","volume":"15","author":"SC Hopp","year":"2018","unstructured":"Hopp SC, Lin Y, Oakley D, Roe AD, DeVos SL, Hanlon D, Hyman BT (2018) The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease. J Neuroinflammation 15: 269","journal-title":"J Neuroinflammation"},{"key":"BFEMMM202216987_CR19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira\u2010Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D et\u00a0al (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575: 669\u2013673","journal-title":"Nature"},{"key":"BFEMMM202216987_CR20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD et\u00a0al (2013) Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12: 207\u2013216","journal-title":"Lancet Neurol"},{"key":"BFEMMM202216987_CR21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J et\u00a0al (2018) NIA\u2010AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement 14: 535\u2013562","journal-title":"Alzheimers Dement"},{"key":"BFEMMM202216987_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze S, Berron D, Smith R, Strandberg O, Proctor NK, Dage JL, Stomrud E, Palmqvist S, Mattsson\u2010Carlgren N, Hansson O (2021) Associations of plasma phospho\u2010tau217 levels with tau positron emission tomography in early Alzheimer disease. JAMA Neurol 78: 149\u2013156","journal-title":"JAMA Neurol"},{"key":"BFEMMM202216987_CR23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","volume":"37","author":"TR Jay","year":"2017","unstructured":"Jay TR, Hirsch AM, Broihier ML, Miller CM, Neilson LE, Ransohoff RM, Lamb BT, Landreth GE (2017) Disease progression\u2010dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease. J Neurosci 37: 637\u2013647","journal-title":"J Neurosci"},{"key":"BFEMMM202216987_CR24","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"SC Jin","year":"2014","unstructured":"Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D, Norton JB, Hsu S, Harari O, Cai Y et\u00a0al (2014) Coding variants in TREM2 increase risk for Alzheimer's disease. Hum Mol Genet 23: 5838\u20135846","journal-title":"Hum Mol Genet"},{"key":"BFEMMM202216987_CR25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10: 698\u2013712","journal-title":"Nat Rev Drug Discov"},{"key":"BFEMMM202216987_CR26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren\u2010Shaul","year":"2017","unstructured":"Keren\u2010Shaul H, Spinrad A, Weiner A, Matcovitch\u2010Natan O, Dvir\u2010Szternfeld R, Ulland TK, David E, Baruch K, Lara\u2010Astaiso D, Toth B et\u00a0al (2017) A unique microglia type associated with restricting development of Alzheimer's disease. Cell 169: 1276\u20131290","journal-title":"Cell"},{"key":"BFEMMM202216987_CR27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Suarez\u2010Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger\u2010Weinzierl A, Mazaheri F et\u00a0al (2014) TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med 6: 243ra286","journal-title":"Sci Transl Med"},{"key":"BFEMMM202216987_CR28","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ et\u00a0al (2015) The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement 11: e11\u2013e14","journal-title":"Alzheimers Dement"},{"key":"BFEMMM202216987_CR29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","volume":"17","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Jones DT, Greicius MD (2021) Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimers Dement 17: 696\u2013701","journal-title":"Alzheimers Dement"},{"key":"BFEMMM202216987_CR30","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O'Loughlin E, Xu Y, Fanek Z et\u00a0al (2017) The TREM2\u2010APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47: 566\u2013581","journal-title":"Immunity"},{"key":"BFEMMM202216987_CR31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5732","volume":"12","author":"R La Joie","year":"2020","unstructured":"La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, Chaudhary K, Edwards L, Iaccarino L, Janabi M et\u00a0al (2020) Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau\u2010PET. Sci Transl Med 12: eaau5732","journal-title":"Sci Transl Med"},{"key":"BFEMMM202216987_CR32","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","volume":"32","author":"SM Landau","year":"2011","unstructured":"Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ, Alzheimer's Disease Neuroimaging Initiative (2011) Associations between cognitive, functional, and FDG\u2010PET measures of decline in AD and MCI. Neurobiol Aging 32: 1207\u20131218","journal-title":"Neurobiol Aging"},{"key":"BFEMMM202216987_CR33","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","volume":"72","author":"SM Landau","year":"2012","unstructured":"Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ, Alzheimer's Disease Neuroimaging Initiative (2012) Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol 72: 578\u2013586","journal-title":"Ann Neurol"},{"key":"BFEMMM202216987_CR34","doi-asserted-by":"crossref","first-page":"12538","DOI":"10.1523\/JNEUROSCI.0853-14.2014","volume":"34","author":"S Lee","year":"2014","unstructured":"Lee S, Xu G, Jay TR, Bhatta S, Kim KW, Jung S, Landreth GE, Ransohoff RM, Lamb BT (2014) Opposing effects of membrane\u2010anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway. J Neurosci 34: 12538\u201312546","journal-title":"J Neurosci"},{"key":"BFEMMM202216987_CR35","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns CEG, Gratuze M, Narasimhan S, Jain N, Koscal LJ, Jiang H, Manis M, Colonna M, Lee VMY, Ulrich JD et\u00a0al (2019) TREM2 function impedes tau seeding in neuritic plaques. Nat Neurosci 22: 1217\u20131222","journal-title":"Nat Neurosci"},{"key":"BFEMMM202216987_CR36","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis N, Xu G, Kokiko\u2010Cochran ON, Jiang S, Cardona A, Ransohoff RM, Lamb BT, Bhaskar K (2015) Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain 138: 1738\u20131755","journal-title":"Brain"},{"key":"BFEMMM202216987_CR37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2387","volume":"6","author":"N Mattsson\u2010Carlgren","year":"2020","unstructured":"Mattsson\u2010Carlgren N, Andersson E, Janelidze S, Ossenkoppele R, Insel P, Strandberg O, Zetterberg H, Rosen HJ, Rabinovici G, Chai X et\u00a0al (2020) Abeta deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer's disease. Sci Adv 6: eaaz2387","journal-title":"Sci Adv"},{"key":"BFEMMM202216987_CR38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","volume":"21","author":"E Morenas\u2010Rodriguez","year":"2022","unstructured":"Morenas\u2010Rodriguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Suarez\u2010Calvet M, Fagan AM, Schultz S, Gordon BA, Benzinger TLS et\u00a0al (2022) Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal\u2010dominant Alzheimer's disease: a longitudinal observational study. Lancet Neurol 21: 329\u2013341","journal-title":"Lancet Neurol"},{"key":"BFEMMM202216987_CR39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/awaa399","volume":"144","author":"A Moscoso","year":"2021","unstructured":"Moscoso A, Grothe MJ, Ashton NJ, Karikari TK, Rodriguez JL, Snellman A, Suarez\u2010Calvet M, Zetterberg H, Blennow K, Scholl M et\u00a0al (2021) Time course of phosphorylated\u2010tau181 in blood across the Alzheimer's disease spectrum. Brain 144: 325\u2013339","journal-title":"Brain"},{"key":"BFEMMM202216987_CR40","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/brain\/aww108","volume":"139","author":"H Oh","year":"2016","unstructured":"Oh H, Madison C, Baker S, Rabinovici G, Jagust W (2016) Dynamic relationships between age, amyloid\u2010beta deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Brain 139: 2275\u20132289","journal-title":"Brain"},{"key":"BFEMMM202216987_CR41","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Scholl M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A et\u00a0al (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain 139: 1551\u20131567","journal-title":"Brain"},{"key":"BFEMMM202216987_CR42","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114398","volume":"13","author":"R Ossenkoppele","year":"2021","unstructured":"Ossenkoppele R, Reimand J, Smith R, Leuzy A, Strandberg O, Palmqvist S, Stomrud E, Zetterberg H, Alzheimer's Disease Neuroimaging Initiative, Scheltens P et\u00a0al (2021) Tau PET correlates with different Alzheimer's disease\u2010related features compared to CSF and plasma p\u2010tau biomarkers. EMBO Mol Med 13: e14398","journal-title":"EMBO Mol Med"},{"key":"BFEMMM202216987_CR43","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/brain\/aww015","volume":"139","author":"S Palmqvist","year":"2016","unstructured":"Palmqvist S, Mattsson N, Hansson O, Alzheimer's Disease Neuroimaging Initiative (2016) Cerebrospinal fluid analysis detects cerebral amyloid\u2010beta accumulation earlier than positron emission tomography. Brain 139: 1226\u20131236","journal-title":"Brain"},{"key":"BFEMMM202216987_CR44","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01150-x","volume":"8","author":"S Palmqvist","year":"2017","unstructured":"Palmqvist S, Scholl M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, Blennow K, Landau S, Jagust W, Hansson O (2017) Earliest accumulation of beta\u2010amyloid occurs within the default\u2010mode network and concurrently affects brain connectivity. Nat Commun 8: 1214","journal-title":"Nat Commun"},{"key":"BFEMMM202216987_CR45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N et\u00a0al (2019) Loss of TREM2 function increases amyloid seeding but reduces plaque\u2010associated ApoE. Nat Neurosci 22: 191\u2013204","journal-title":"Nat Neurosci"},{"key":"BFEMMM202216987_CR46","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, Savard M, Lussier FZ, Tissot C, Karikari TK et\u00a0al (2021) Microglial activation and tau propagate jointly across Braak stages. Nat Med 27: 1592\u20131599","journal-title":"Nat Med"},{"key":"BFEMMM202216987_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34129-4","author":"A Pichet Binette","year":"2022","unstructured":"Pichet Binette A, Franzmeier N, Spotorno N, Ewers M, Brendel M, Biel D, Weiner M, Aisen P, Petersen R, Jack CR et\u00a0al (2022) Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer\u2019s disease. Nat Commun 13 https:\/\/doi.org\/10.1038\/s41467\u2010022\u201034129\u20104","journal-title":"Nat Commun"},{"key":"BFEMMM202216987_CR47","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2021","unstructured":"R Core Team (2021) R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing"},{"key":"BFEMMM202216987_CR48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13195-021-00836-1","volume":"13","author":"SK Royse","year":"2021","unstructured":"Royse SK, Minhas DS, Lopresti BJ, Murphy A, Ward T, Koeppe RA, Bullich S, DeSanti S, Jagust WJ, Landau SM et\u00a0al (2021) Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach. Alzheimers Res Ther 13: 99","journal-title":"Alzheimers Res Ther"},{"key":"BFEMMM202216987_CR49","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1007\/s00259-022-05897-4","volume":"49","author":"G Salvado","year":"2022","unstructured":"Salvado G, Mila\u2010Aloma M, Shekari M, Ashton NJ, Operto G, Falcon C, Cacciaglia R, Minguillon C, Fauria K, Ninerola\u2010Baizan A et\u00a0al (2022) Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum. Eur J Nucl Med Mol Imaging 49: 4567\u20134579","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BFEMMM202216987_CR50","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1093\/cercor\/bhx179","volume":"28","author":"A Schaefer","year":"2018","unstructured":"Schaefer A, Kong R, Gordon EM, Laumann TO, Zuo XN, Holmes AJ, Eickhoff SB, Yeo BTT (2018) Local\u2010global parcellation of the human cerebral cortex from intrinsic functional connectivity MRI. Cereb Cortex 28: 3095\u20133114","journal-title":"Cereb Cortex"},{"key":"BFEMMM202216987_CR51","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000571","volume":"7","author":"SE Schindler","year":"2021","unstructured":"Schindler SE, Cruchaga C, Joseph A, McCue L, Farias FHG, Wilkins CH, Deming Y, Henson RL, Mikesell RJ, Piccio L et\u00a0al (2021) African Americans have differences in CSF soluble TREM2 and associated genetic variants. Neurol Genet 7: e571","journal-title":"Neurol Genet"},{"key":"BFEMMM202216987_CR52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1742-2094-7-64","volume":"7","author":"Z Stozicka","year":"2010","unstructured":"Stozicka Z, Zilka N, Novak P, Kovacech B, Bugos O, Novak M (2010) Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease. J Neuroinflammation 7: 64","journal-title":"J Neuroinflammation"},{"key":"BFEMMM202216987_CR53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awab294","volume":"145","author":"A Strom","year":"2022","unstructured":"Strom A, Iaccarino L, Edwards L, Lesman\u2010Segev OH, Soleimani\u2010Meigooni DN, Pham J, Baker SL, Landau SM, Jagust WJ, Miller BL et\u00a0al (2022) Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease. Brain 145: 713\u2013728","journal-title":"Brain"},{"key":"BFEMMM202216987_CR54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Suarez\u2010Calvet","year":"2016","unstructured":"Suarez\u2010Calvet M, Kleinberger G, Araque Caballero MA, Brendel M, Rominger A, Alcolea D, Fortea J, Lleo A, Blesa R, Gispert JD et\u00a0al (2016) sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early\u2010stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol Med 8: 466\u2013476","journal-title":"EMBO Mol Med"},{"key":"BFEMMM202216987_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Suarez\u2010Calvet","year":"2019","unstructured":"Suarez\u2010Calvet M, Morenas\u2010Rodriguez E, Kleinberger G, Schlepckow K, Araque Caballero MA, Franzmeier N, Capell A, Fellerer K, Nuscher B, Eren E et\u00a0al (2019) Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related\u2010neurodegeneration but not with amyloid\u2010beta pathology. Mol Neurodegener 14: 1","journal-title":"Mol Neurodegener"},{"key":"BFEMMM202216987_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Su\u00e1rez\u2010Calvet","year":"2019","unstructured":"Su\u00e1rez\u2010Calvet M, Morenas\u2010Rodr\u00edguez E, Kleinberger G, Schlepckow K, Caballero M\u00c1A, Franzmeier N, Capell A, Fellerer K, Nuscher B, Eren E et\u00a0al (2019) Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related\u2010neurodegeneration but not with amyloid\u2010\u03b2 pathology. Mol Neurodegener 14: 1","journal-title":"Mol Neurodegener"},{"key":"BFEMMM202216987_CR57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","volume":"7","author":"T Vogels","year":"2019","unstructured":"Vogels T, Murgoci AN, Hromadka T (2019) Intersection of pathological tau and microglia at the synapse. Acta Neuropathol Commun 7: 109","journal-title":"Acta Neuropathol Commun"},{"key":"BFEMMM202216987_CR58","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamaneurol.2016.2078","volume":"73","author":"L Wang","year":"2016","unstructured":"Wang L, Benzinger TL, Su Y, Christensen J, Friedrichsen K, Aldea P, McConathy J, Cairns NJ, Fagan AM, Morris JC et\u00a0al (2016) Evaluation of tau imaging in staging Alzheimer disease and revealing interactions between beta\u2010amyloid and tauopathy. JAMA Neurol 73: 1070\u20131077","journal-title":"JAMA Neurol"},{"key":"BFEMMM202216987_CR59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe5640","volume":"13","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, Beyer L, Biechele G, Eckenweber F, Zatcepin A et\u00a0al (2021) Microglial activation states drive glucose uptake and FDG\u2010PET alterations in neurodegenerative diseases. Sci Transl Med 13: eabe5640","journal-title":"Sci Transl Med"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.202216987.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.202216987","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.202216987\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.202216987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.202216987.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:44:47Z","timestamp":1779086687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.202216987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,8]]}},"alternative-id":["BFEMMM202216987"],"URL":"https:\/\/doi.org\/10.15252\/emmm.202216987","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"EMMM202216987"}}